Washington State Convention Center | Seattle
April 2-6 | Exhibit Dates: April 3-5
April 6 | ACMG/SIMD Joint Session

Catalyst Pharmaceuticals

Coral Gables,  FL 
United States
http://www.catalystpharma.com
  • Booth: 401

Catalyst Pharmaceuticals Booth #401

Profile

Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, including Lambert-Eaton myasthenic syndrome (LEMS), congenital myasthenic syndromes (CMS), MuSK antibody positive myasthenia gravis, and spinal muscular atrophy (SMA) type 3. For more information on our work, please visit www.catalystpharma.com.